Using CRISPR-Cas9 technology, sgRNA sequences targeted to the kinase domain of the Map3k13 gene were designed. Two KO mouse lines were obtained and the one containing a deletion of the entire kinase domain was used in this study. (J:316717)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count